CYP1A1 and cancer: Future development and application of various antioxidants, small molecule inhibitors, targeting antibodies and other novel methods against ROS, EGF, IL-1α, ADAM, JAK, Src, MEK, CYP1A1, and COX signal transduction pathways can be used for prevention or treatment of BQ chewing-related cancer and other diseases in the future.